Novus Biologicals™ RIPK1/RIP1 Antibody Blocking Peptide

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino acids near the amino terminus of human RIPK1. Source: Synthetic (Accession #: NP_003795) The RIPK1/RIP1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 8737
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-77077. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: Cell death protein RIP, EC 2.7.11.1, receptor (TNFRSF)-interacting serine-threonine kinase 1, receptor interacting protein, Receptor-interacting protein 1, receptor-interacting serine/threonine-protein kinase 1, RIP1, RIP-1, Rip1 kinase, RIPFLJ39204, Serine/threonine-protein kinase RIP
• Gene Symbol: RIPK1
• Product Type: RIPK1
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino acids near the amino terminus of human RIPK1